Institute of Physical Medicine and Rehabilitation, Social Medical Centre South
Vienna, State of Vienna, 1100, Austria
NCT Number: NCT00635440
Skeletal muscle atrophy is associated with catabolic conditions such as major surgical interventions and leads to reduced muscle strength, increased clinical complications and prolonged convalescence. Several studies revealed immobilisation as a major stimulus for muscle wasting in severely ill patients. This study investigates the potency of neuromuscular electrical stimulation on skeletal muscle growth factors and degradation processes in major abdominal surgery patients.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Vienna, State of Vienna, 1100, Austria
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Electrical stimuli of 50 Hz (pulse width 0.25ms, 8 sec on, 4 sec off) were applied daily for 30 min, for 4 days, starting on the first postoperative day.The amplitude of the electrical stimuli in the stimulated leg was adjusted to ensure maximum tolerable muscle contraction.
Medical University of Vienna
Other
The Effect of Neuromuscular Electrical Stimulation on Muscle Metabolism of Major Abdominal Surgical Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05156320
Anti-myostatin, Atrophy
Birmingham, Alabama, United States
View Trial DetailsNCT06233825
Anterior Cruciate Ligament Reconstruction, Atrophy
Kingston, Ontario, Canada
View Trial DetailsNCT02912130
Atrophy, Behavior
Liverpool, Merseyside, United Kingdom
View Trial DetailsNCT03921528
Atrophy, Central Nervous System Diseases
Phoenix, Arizona, United States
View Trial Details